
Alex Shved
Alex Shved is a 37-year-old father from Etobicoke, Ontario, who is fighting for access to tumor-infiltrating lymphocyte (TIL) therapy for metastatic melanoma. Despite Health Canada approving the treatment, he has been denied out-of-country coverage by OHIP, leaving him to appeal the decision in hopes of receiving the life-saving therapy that he believes is crucial for his survival and for the sake of his two young daughters.
Country presence
Recent news mentions
Alex Shved, a 37-year-old Etobicoke resident, had challenged the province’s decision and said Tuesday that the court’s judgment validates arguments he has put forward in his fight to see public drug coverage for tumour-infiltrating lymphocyte (TIL) therapy.
Ontario court sides with patient appealing province’s refusal to cover out-of-country cancer treatmentAlex Shved is appealing OHIP’s decision to deny his out-of-country coverage for cancer treatment.
Despite approval from Health Canada, delay in cancer drug funding leaves patients in limbo








